Apr 06, 2017 12:31 pm UTC| Business
MIAMI, April 06, 2017 -- Next Group Holdings, Inc. (OTCQB:NXGH) (the "Company") announced today that it has signed a Letter of Intent (“LOI”) to acquire AZUGROUP, a leader in the plastic/paper debit, credit, gift card...
Apr 06, 2017 12:31 pm UTC| Business
NOVATO, Calif.and LONDON, April 06, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Kyowa Kirin International PLC (KKI), a wholly owned subsidiary of Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), today...
Willis Towers Watson Announces CFO Retirement, Effective Fall 2017
Apr 06, 2017 12:30 pm UTC| Business
ARLINGTON, Va. and LONDON, April 06, 2017 -- Willis Towers Watson (NASDAQ:WLTW), a leading global advisory, broking and solutions company, announced today that Roger Millay, Willis Towers Watson’s Chief Financial...
Colombo Stock Exchange Designated as Qualified Foreign Exchange by OTC Markets Group
Apr 06, 2017 12:30 pm UTC| Business
NEW YORK, April 06, 2017 -- Launchpad announces the Colombo Stock Exchange has been designated as a Qualified Foreign Exchange by OTC Markets Group Inc., effective Friday, the 24th of March. As a result, effective...
Impinj to Announce First Quarter 2017 Financial Results
Apr 06, 2017 12:30 pm UTC| Business
SEATTLE, April 06, 2017 -- Impinj, Inc. (NASDAQ:PI), a leading provider and pioneer of RAIN RFID solutions for identifying, locating and authenticating everyday items, today announced it will release financial results...
ADT Hits Industry Milestone; Company Announces 2 Millionth ADT Pulse Home Automation Customer
Apr 06, 2017 12:30 pm UTC| Business
BOCA RATON, Fla., April 06, 2017 -- Last month, ADT LLC, a leading provider of security and automation solutions for homes and businesses, surpassed the 2 million customer milestone for its groundbreaking Pulse...
Adverum Biotechnologies to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day
Apr 06, 2017 12:30 pm UTC| Business
MENLO PARK, Calif., April 06, 2017 -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a leading gene therapy company advancing novel medicines to address unmet needs in serious rare and ocular diseases, announced today...